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Use of Palmaz Stents in a Newborn With Congenital
Aneurysms and Coarctation of the Abdominal Aorta
J. Ballweg, MD, R. Liniger, BS, A. Rocchini, MD, and R. Gajarski,* MD
Anomalies of the abdominal aorta are rare in the pediatric population limiting the
reported knowledge base from which management decisions can be made. A 3-week-
old male with congenital abdominal aortic coarctation and multiple aneurysms pre-
sented with malignant hypertension. We report the safe deployment of overlapping
Palmaz stents using a 4-French catheter delivery system with significant relief of the
coarctation gradient and restoration of adequate renal perfusion. ' 2006 Wiley-Liss., Inc.
Key words: abdominal coarctation; stents; interventional catheterization
INTRODUCTION
Among pediatric patients, the most common etiology
for coarctation of the abdominal aorta is Takayasu’s
arteritis, which, rarely, can also accompany aneurysms.
In the absence of coarctation, abdominal aortic aneur-
ysms are often associated with connective tissue dis-
ease, umbilical artery catheterization, and infectious or
vasculitic processes. Multiple congenital abdominal
aortic aneurysms are exceedingly rare with only five
cases reported in live infants [1–5]. Uncontrolled hyper-
tension from chronic renin–angiotensin activation, gastro-
intestinal tract ischemia, renal failure, aneurysm rupture,
cardiac hypertrophy, and arrhythmias are potentially
life threatening sequelae of untreated disease. Abdomi-
nal coarctation, as the primary source of clinical pa-
thology, in conjunction with multiple aneurysms has
not been previously reported and presents a uniquely
challenging management problem. Interventional cathe-
terization techniques utilizing stents to relieve coarcta-
tion of the aorta [6–8] as well as surgical repairs have
been previously described in older children and adults
[9–12]. There are currently no reports describing the
use of stents for abdominal coarctation in newborns or
infants, likely related to the previous lack of an appro-
priately sized delivery system and the limited potential
for adequate stent redilation with somatic growth. Our
patient was a 3-week-old with both congenital aneur-
ysms and abdominal coarctation involving the renal
arteries. To our knowledge, this is the first reported
neonate with concomitant congenital abdominal aneur-
ysms and coarctation successfully treated with Palmaz
stents.
CASE REPORT
A term male weighing 2.93 kg born to a healthy 34-
year-old G2P1 woman at an outside hospital was
known to have an aortic aneurysm by prenatal ultra-
sound. At 2 weeks of age, his primary care physician
found him to be hypertensive with an upper extremity
blood pressure of 185/135 mm Hg, after which he was
admitted to the local neonatal ICU. Angiography dem-
onstrated multiple abdominal aortic aneurysms involv-
ing the right iliac artery as well as a hypoplastic right
renal artery. No family history of early renal failure,
dialysis, need for renal transplant, malignant hyperten-
sion, Marfan’s Disease, Ehlers–Danlos, or other con-
nective tissue disorders was elicited.
The infant was transferred to the University of
Michigan at 3 weeks of age on nitroprusside and
esmolol infusions to maintain systolic blood pressures
of 100–110 mm Hg to ensure adequate renal perfusion.
Additionally, heparin anticoagulation had been initiated
prior to transfer following detection of aortic aneurysm
thrombus. On admission, right upper extremity blood
pressure was 94/53 mm Hg and left lower extremity
blood pressure was 33 mm Hg systolic (no diastolic as
this was measured by Doppler probe). Additional phys-
ical exam revealed the presence of posteriorly rotated
ears, mild micrognathia, a 2/6 systolic murmur radiat-
ing to back, midline bruit (no epigastic pulsations noted),
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weak femoral pulses, and talipes equinovarus, bilater-
ally. No laboratory evidence for infectious or inflam-
matory processes, including an ESR 11, negative blood
and urine cultures and low viral antibody titers, was
found. Chromosomal FISH analysis did not identify a
22q11 microdeletion or other genetic anomalies. An
echocardiogram revealed normal intracardiac anatomy
with normal systemic and pulmonary venous return, pa-
tent foramen ovale with left to right shunting, no ven-
tricular septal defect, moderate concentric left ventricu-
lar hypertrophy, and good biventricular function. Mag-
netic resonance angiography (MRA) of the brain,
chest, and abdomen revealed three abdominal aortic
aneurysms extending to the iliac bifurcation, as well as
severe coarctation/stenosis between aneurysm segments
and hypoplastic renal arteries (Fig. 1).
With this data, the baby was taken to the cardiac
catheterization laboratory for further anatomic delinea-
tion by angiography and stent implantation in an effort
to relieve the coarctation, improve renal blood flow,
and decrease systemic hypertension. Anatomy similar
to that identified by MRA was demonstrated (Fig. 2)
with a peak gradient across the coarctation of 53 mm
Hg. Recorded dimensions included proximal descend-
ing aorta 6.3 mm, area of coarctation 2 mm, distal de-
scending aorta past renal arteries 10 mm, distal aorta
at level of iliac bifurcation 6.3 mm, proximal right
femoral artery 3 mm. There were four aneurysms,
measuring 16.7 3 17.8 mm2, 11.1 3 10.3 mm2, 23.8 3
19.8 mm2, and 9.8 3 13 mm2. Using interventional
techniques previously described, [13] three Palmaz Co-
rinthian PQ124 stents were placed in an overlapping
configuration through the region of abdominal coarcta-
tion followed by the placement of a Palmaz Genesis
PG184 stent at the most distal aspect of narrowing via
a 4-French catheter delivery system. The most proxi-
mal stent was initially inflated using a 4-mm Ranger
balloon, followed by inflation with a 5-mm Tyshak II
Fig. 1. Coronal view MRI image demonstrates the location of the lower thoracic and abdom-
inal aortic coarctations (arrows) near the level of the diaphragm with intersegment coarcta-
tion (arrow). Note that the renal and femoral arteries are hypoplastic.
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balloon. All of the subsequent stents were inflated
using a 4-mm Ranger Balloon catheter. Following stent
implantation, there was a 60% reduction in the peak
systolic gradient from 53 to 21 mm Hg. Additionally,
there was no evidence of aortic tear, dissection or con-
trast extravasation (Fig. 3). The baby tolerated the pro-
cedure well and was transferred to the cardiac inten-
sive care unit. No femoral pulses could be palpated af-
ter return to the ICU, and they remained absent at the
time of discharge from the hospital.
Following the interventional procedure, the infant
maintained systolic blood pressures below 120 mm Hg
on oral amlodipine and propranolol. Because of previ-
ously noted thrombus, we chose more aggressive anti-
coagulation with Coumadin (target INR 1.5–2.0). He
was discharged after a total hospital stay of 10 days
with normal renal function.
On an antihypertensive regimen including amlodi-
pine 4 mg bid, labetalol 24 mg bid, and aldactone 2.5 mg
bid, a repeat catheterization 4 months later revealed a
left ventricular pressure of 124/16 mm Hg, and ascend-
ing/descending thoracic aortic pressures of 125/68 mm
Hg. The abdominal aortic pressure waveform distal to
the multiple stents was non-pulsatile, with a mean
pressure of 74 mm Hg. Cineangiograms demonstrated
a normal appearing aorta to the level of the diaphragm.
The internal lumen of the stented portion of the ab-
dominal aorta varied from 2.5 to 3.5 mm in diameter.
A short gap had developed between the first and sec-
ond stents. All other stents remained overlapped. No
excessive neointimal proliferation was identified within
any of the stents. Marked ectatic changes of the ab-
dominal aorta were recorded distal to the last stent,
with an aortic diameter of 12–15 mm. The superior
mesenteric artery and renal arteries arose from this
ectatic portion of the aorta. Both right and left renal
arteries filled without evidence of renal artery stenosis.
No thrombosis was noted within the aorta or within
the saccular aneurysms.
At the time of catheterization, it was known that the
infant had developed a large, retroperitoneal myofi-
broma, which was compressing the spinal cord at the
level of L2 with resultant neurologic symptoms. He
underwent resection of the tumor 2 weeks after the
catheterization and was discharged.
DISCUSSION
Stent placement can be very effective in relieving
arch obstruction safely and has become a frequently
used alternative form of therapy in patients with native
or recurrent coarctation. Stents support the integrity of
the vessel wall after balloon dilation by opposing the
recoil of the elastic vascular stenosis and reapplying
the torn intima to the media. This minimizes the exten-
sion of wall tears and subsequent dissection or aneu-
rysm formation that could occur after balloon angio-
plasty alone.
Limited data is available in regard to stent therapy
in young children. In three large series, five small
Fig. 2. AP and lateral projections of the thoracic and abdominal aorta (left and right images,
respectively). Note appearance of coarctation segment (arrow) and location of aneurysms
corroborate MRI image.
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children, including two infants, underwent stent im-
plantation, with the majority having had previous sur-
gical and or balloon dilation interventions. Stent im-
planation has also been described in a neonate who
was deemed too unstable for surgical repair of tho-
racic aortic coarctation. Limitations to stent placement
in infants and young children include the lack of
small delivery systems, the higher rate of restenosis
from neointimal thickening, [14] as well as the inability
to place a stent whose maximal diameter will reach
normal adult aortic size resulting in stent-mediated
stenosis.
The use of covered stents in the setting of vascular
aneurysms is well documented. The use of Palmaz
stents in the setting of coarctation and saccular aneu-
rysm in children has been described by Suarez de Lezo
et al. Their findings suggest that the blood column
favored by the stent tube could partially isolate the
covered sac from the bloodstream, enabling exclusion
or an inhibition of growth with advancing age [15].
Alternatively, coil obliteration of the cavity excluding
the aneurysm completely from the blood surface has
also been demonstrated.
This case demonstrates an infant with multiple areas
of abdominal coarctation in association with congenital
aneurysms. The arch obstruction was adequately relieved
by stent placement. Multiple aneurysms were isolated
as well by the serial, overlapping stents. Thrombus,
which was initially noted within the aneurysms subse-
quently resolved after stent placement and anticoagula-
tion. The hypertension has been adequately controlled
with relief of the arch obstruction in conjunction with
antihypertensive agents. Renal blood flow has been
preserved with the current therapies. Renal revasculari-
zation may become necessary if the renal arteries
become stenotic or obstructed by the aortic stents or if
hypertension cannot be reasonably controlled by oral
antihypertensive medications. Finally, redilatation of
the stents will be necessary to maintain the abdominal
aorta free of obstruction. Unfortunately, the stents uti-
lized in this case can only safely be redilated to a
maximum diameter of 11 mm. Since it is likely that
this diameter will be inadequate with somatic growth
of this infant, surgical augmentation of the aorta with
prosthetic graft material (including the stented areas)
will be necessary at a future time.
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